Lymphomas
A PHASE III, MULTICENTER, RANDOMIZED, OPEN LABEL STUDY COMPARING THE EFFICACY AND SAFETY OF GLOFITAMAB (RO7082859) IN COMBINATION WITH POLATUZUMAB VEDOTIN PLUS RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE (POLA-R-CHP) VERSUS POLA R CHP IN PREVIOUSLY UNTREATED PATIENTS WITH LARGE B-CELL LYMPHOMA (GO44145)
- Details
ClinicalTrials.gov ID:
NCT06047080
Diagnosis Type:
NA
USOR Number:
- Address
,
P: